Ocular Hypotensive Effect of the Rho Kinase Inhibitor AR-12286 in Patients With Glaucoma and Ocular Hypertension
- 30 November 2011
- journal article
- research article
- Published by Elsevier BV in American Journal of Ophthalmology
- Vol. 152 (5), 834-841.e1
- https://doi.org/10.1016/j.ajo.2011.04.012
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effects of Fasudil, a Rho-Associated Protein Kinase Inhibitor, on Optic Nerve Head Blood Flow in RabbitsInvestigative Ophthalmology & Visual Science, 2011
- Delaying Treatment of Ocular HypertensionJAMA Ophthalmology, 2010
- Y-27632, a Rho-associated protein kinase inhibitor, attenuates neuronal cell death after transient retinal ischemiaAlbrecht von Graefes Archiv für Ophthalmologie, 2007
- Effects of Topical Administration of Y-39983, a Selective Rho-Associated Protein Kinase Inhibitor, on Ocular Tissues in Rabbits and MonkeysInvestigative Ophthalmology & Visual Science, 2007
- Effects of the Rho kinase inhibitor Y-27632 and the phosphatase inhibitor calyculin A on outflow facility in monkeysExperimental Eye Research, 2005
- Targeting Outflow Facility in Glaucoma ManagementSurvey of Ophthalmology, 2003
- Reduction of Intraocular Pressure and Glaucoma ProgressionAmerican Journal of Ophthalmology, 2002
- The Ocular Hypertension Treatment StudyAmerican Journal of Ophthalmology, 2002
- Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgeryOphthalmology, 2001
- The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deteriorationAmerican Journal of Ophthalmology, 2000